On July 31st, 2023, GSK – a global pharmaceutical company shared that their anticancer medication Jemperli (Dostarlimab -glxy) has been approved by the US Food and Drug Administration (FDA) for use in combination with chemotherapy drugs paclitaxel and carboplatin.GSK’s Jemperli was first approved by the FDA in April 2021 for monotherapy in adult patients with advanced or recurrent endometrial cancer that is DNA mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H).The expanded approval of this medication comes after the latest clinical trial ‘RUBY’ which demonstrated a positive impact of Jemperli combined with Chemotherapy in all patients. The recent FDA approval of this combination of treatments is a major advancement in the treatment of endometrial cancer in adult p...

India is one of the biggest hubs for the E-commerce industry. Companies like Amazon and Flipkart have been enjoying a duopoly in the Indian e-commerce market ever since Alibaba got banned in India. Many other companies in the sector, like Nykaa, Reliance Digital, Tata CLiQ, Myntra, Meesho, and IndiaMART, are expanding their market share in the Indian e-commerce market. The growing Indian e-commerce industry is creating enormous opportunities for large e-commerce players to cater to the industry's growth. Today, e-commerce giant, Walmart buys a $1.4 billion stake from Tiger Global in one of India's most popular e-commerce firms, Flipkart. Before diving into the exact deal between Walmart and Tiger Global in Flipkart and its impact on market positioning, let’s take an overview of the Indi...

Upon the termination of the deal between Vedanta and Foxconn, concerns arose globally about India's standing in the semiconductor development industry, with many asserting that progress had backslided due to the difficulty in securing new investments. However, India has addressed these apprehensions with a recent announcement of a substantial investment in the semiconductor industry. AMD, an American Chipmaker, has announced to invest $400 million by 2028 in India. They plan to establish a semiconductor plant in Gujrat and the largest chip design center in Bengaluru, the tech hub.The breakup of the Vedanta-Foxconn deal was attributed to the unavailability of technology and the inability to find a suitable supplier, as mentioned in their official statement. To bolster the semiconductor p...

The global Toy Market has been long dominated by video games, consoles, and Legoes and it somewhere still does but also the shift of the global Toy Market towards Science, Technology, Engineering, and Mathematics (STEM) Toys should be noted. The major reason behind the change is the growing awareness of education while playing. With the help of STEM Toys, a kid can learn important science/math concepts while enjoying it. In a report by OMR, the Global STEM Toy market is projected to grow by a solid CAGR of 7.1% during 2021-27.STEM toys are not just being limited to home but also schools are encouraging their usage to engage students during the learning process. Organizations like The Toy Association have launched a new series of STEM toys including 30 new products to build skills in sci...

The automotive industry in India is one of the key contributors to the economic growth of the country. India is predicted to become 3rd largest automotive market by 2030. India’s annual production of automobile including tractor, bus, heavy-truck, passenger vehicles, three-wheelers, two-wheelers, and quadri-cycles was 22.93 million vehicles in FY22. The automotive industry is accounted for 6.4% of total GDP and 35% of its manufacturing GDP. With the high growth of Indian automotive industry now the target for export has increased by five times during year 2016-26 and during FY22 the export by automotive industry was recorded 5,617,246 units (IBEF.org, 2023). Indian automotive industry is highly responsible for creating employment supporting a large pool of skilled people. India's abilit...

With growing fossil fuel prices and energy security concerns, the global power crisis is growing severely and encouraging the world to fasten the development towards renewable energy sources such as solar, wind, and hydro. According to a report by International Energy Agency (IEA), solar energy is ready to record the largest annual growth in new renewable energy capacity ever. Global renewable capacity additions are set to soar by 107 gigawatts (GW), the largest absolute increase ever, to more than 440 GW in 2023.The report also suggested that the contribution of solar energy was the highest in this gigantic growth of the renewable energy industry. To support the argument the data presented by IEA suggested that Solar PV’s power capacity is expected to surpass that of coal by 2027, beco...

AI and Its Intervention in Global MarketArtificial Intelligence (AI) is one of the most discussed revolutions of the current global scenario. It is bringing big changes in every industry all around the world. AI with new technologies, regular updates and consistent innovation is helping industries to break all the conventional working processes and bringing more accuracy and credibility to the global market. There is no industry which has been left untouched by the intervention of AI in the global market and one of the most talked about in them is Healthcare Industry. With the help of AI not just big innovations are being experienced in healthcare but also day-to-day health check has been possible because of the technology like Smart Watch and Fit-Band,AI Disrupting Healthcare and Chang...

On June 28, 2023, Pfizer Inc. and OPKO Inc. announced that their growth hormone NGENLA (somatrogon-ghla) has finally been approved by the US Food and Drugs Administration (FDA) for a once-a-week dosage to treat pediatric Growth Hormone Deficiency (GHD). Last year, the FDA approved NGENLA for marketing, however, they did not provide approval for usage.Developed as a part of the Next Generation of Long-Acting Growth Hormone (LAGH), NGENLA is a human growth hormone analogue that is presented by the partnership of Pfizer Inc. and OPKO Inc. to treat GHD in pediatric patients of ages 3 and above. This LAGH can be administered once a week as a subcutaneous injection to pediatric patients of ages 3 and above that are suffering from GHD. Compared to Pfizer’s previous once-daily growth hormone GE...

On June 15, 2023, Roche’s independent subsidiary and biotechnology company – Genentech, announced that their bispecific antibody Columvi (glofitamab-gxbm) has been given accelerated approval by The US Food and Drugs Administration (FDA). This accelerated approval is a result of the positive results that Columvi demonstrated in clinical trials in patients with relapsed or refractory (R/R) diffuse large B cell Lymphoma (DLBCL). These patients received fixed-duration administration of Columvi and durable remission was observed in them, with a chance of complete remission. Explore quality insights into the Global Non-Hodgkin Lymphoma Treatment Market and learn about the emerging trends, market size, major players, and the latest FDA approvals. Find more quality information on this by access...

On July 17, 2023, it was announced by the U.S. Food and Drug Association have approved Sanofi and AstraZeneca’s jointly developed medicine Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in newborns and infants.RSV is a virus that affects people of all ages, causing short-term respiratory infections in them. RSV usually only brings mild symptoms such as cold and cough in most infants and children. However, it has been shown to be more harmful to some infants – causing lower respiratory tract disease in them, which might require hospitalization. This is especially true for infants dealing with their first infection. They might develop lower respiratory tract diseases such as bronchiolitis and pneumonia – which can be cri...